Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions

Documenti analoghi

• A drug–drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5‐lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam
  di: Jane Knöchel, et al.
  Pubblicazione: (2024)
• Single‐dose and steady‐state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug–drug interaction study
  di: Amelie Leutzendorff, et al.
  Pubblicazione: (2024)
• Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis
  di: Megan Palmer, et al.
  Pubblicazione: (2025)
• Clozapine and norclozapine pharmacokinetic interaction with pantoprazole
  di: Orwa Albitar, et al.
  Pubblicazione: (2026)
• Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
  di: Dave Singh, et al.
  Pubblicazione: (2026)